ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Annual Report Finds Cancer Incidence And Death Rates Fell For First Time.

December 5, 2008

ACS Research Budget Over $82 Million

July 17, 1987

In Brief: New Cancer control Program On Schedule; NCI Expects 10-15CCRU, 30-40 CCSP Applications

July 2, 1982

Shubik Subcommittee Fails To Agree On Draft Document

February 13, 1976

Mammography Hazard In ACS-NCI Screening Charged

October 17, 1975

More Patients Get Screened, Colorectal Death Rates Drop

July 29, 2011